Generic Name and Formulations:
Antazoline phosphate 0.5%, naphazoline HCl 0.05%; oph. soln; contains benzalkonium chloride.
- Diagnosis, Treatments Affected by Amyloid Results in Dementia, Nondementia Patients
- NAPNAP, Nursing Coalition Community Oppose Border Separation of Children From Families
- Schizophrenia, Major Depressive Disorder, Bipolar Disorder Linked With Abnormal Functional Connectivity
Indications for VASOCON-A:
Temporary relief of ocular redness and itching.
Adults and Children:
<6yrs: not recommended. ≥6yrs: 1–2 drops up to 4 times daily.
Narrow-angle glaucoma. Concurrent MAOIs. Contact lens wear.
Avoid prolonged use. Hypertension. Cardiovascular disease. Urinary hesitancy. Diabetes. Pregnancy. Nursing mothers.
Hypertensive crisis with MAOIs.
Mydriasis, increased IOP, local irritation, allergic dermatitis, sensitization, systemic effects if absorbed, may precipitate narrow-angle glaucoma.